Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation.

Similar documents
Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release

Naloxone for Opioid Safety

1/23/2015. Disclosure. Overview. A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care

The Nova Scotia Take Home Naloxone Program. Amanda Hudson-Frigault, MA NS THN Coordinator

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition

APPENDIX: Key summary of six US-based naloxone distribution programs

Reducing opioid overdose mortality: role of communityadministered

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

RESIDENTIAL SUBSTANCE ABUSE TREATMENT (RSAT)

Prevention and Harm Reduction Collaborating to Address Opioid-Related Overdose

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Closing the Loop in Treating Opioid Addiction:

Opportunities for Opioid Safety and Community-Based Overdose Management

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

Good Samaritan. State with this law in place: New Mexico, Washington, New York, Connecticut, Illinois (to be enforced June 1, 2012)

Preventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction

Mobilizing a Response to the Opioid Epidemic: County Snapshots. Kelly Pfeifer, MD May 10, 2018

Naloxone (Narcan) Initiatives and the Court System

Combating Opioid-related Overdose

Heroin Use in Illinois: A Ten-Year Multiple Indicator Analysis, 1998 to 2008

Workshop: A roadmap for overdose prevention policies: where do you fit?

Clackamas County Overdose Prevention and Recovery Support Projects. Apryl L. Herron, MPH Clackamas County Public Health Division

Best Practices for Successful Reentry for People with an Opioid Addiction

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

Pharmacotherapy for Opioid Dependence in Correctional Settings: Research Findings and Recommendations

Protecting and Promoting Health and Equity

Coalition Strategies Across The Continuum of Care

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

2 nd Bernalillo County Opioid Abuse Accountability Summit Data Series January 8, 2015

Harm Reduction Coalition DOPE Project Eliza Wheeler 1440 Broadway Suite 902 Oakland, CA

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

Mortality Among Young Injection Drug Users in San Francisco: A 10-Year Follow-up of the UFO Study

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

Overdose Prevention: Empowering School Personnel & Families

Syringe Exchange Research Update Harm Reduction Coalition August 2008

Overdose follow-up interventions:

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders

Naloxone for opioid safety

Narrative Science-based literature on Syringe Exchange Programs (SEPs)

DUAL DIAGNOSIS CROSS-FUNCTIONAL TEAM

Rural Prevention and Treatment of Substance Abuse Toolkit

John Szyler. Aka Division Street Formulated Recovery as Any Positive Change. Died of OD/AIDS in May 1996

High Impact Prevention for People Who Inject Drugs. June 30, 2015

gatewaycorrections.org TCU & Gateway Foundation 9/23/2014 Disclosures Topics Covered Opioid Use Disorders & the CJ System

Culture and Infection: Understanding Risk-Taking Among Heroin Users in San Francisco

Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

Factors Associated with Syringe Sharing Among Users of a Medically Supervised Safer Injecting Facility

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Circumstances and Witness Characteristics Associated With Overdose Fatality

Opportunities for Engaging Partners to Prevent Opioid Overdose-related Deaths

Nevada Rural Opioid Overdose Reversal (NROOR) Program Overview and Update

Temple University Beasley School of Law. Project on Harm Reduction in the Health Care System

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

How serious is the opiate problem in Fairfield County?

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

The Opioid Crisis in Minnesota: On the Ground Approaches. Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP

Drug Overdose Prevention Program (DOPP)

Data Driven Strategies

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS

PORT GAMBLE S KLALLAM TRIBE. Tribal Opioid Response Plan

Lifetime Benefits and Costs of Diverting Substance Abusing Offenders from State Prison

DPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH

NCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Medicaid Transformation Project

Changing Course: statewide efforts to combat the opioid epidemic in California

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region

SUMMARY OF STUDIES: MEDICAID / HEALTH SERVICES UTILIZATION AND COSTS

King County (Seattle Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018

Take Home Naloxone Report on supply and use to reverse an overdose

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

Spring 2014 Heroin Prevention Program Pilot: Evaluation Report Executive Summary

Evaluations. Viewer Call-In. Guest Speakers. What s New in AIDS/HIV? Phone: Fax: Thank You to our Sponsors

illicit drug reporting system drug trends bulletin

8/12/2013. Drug overdose death rates in the US have more than tripled since 1990 (CDC 2011).

Drug Class Review: Opioid Reversal Agents

Making Naloxone available to potential overdose witnesses: evidence and policy opportunities

Take-Home Naloxone for Opioid Overdose: Exploring the Legal, Policy and Practice Landscapes

Additional North Carolina Projects

TC Treatment for Female Offenders: Outcomes at 6- &12- Months Post-Prison Release

From Medicaid Transformation Approved Project Toolkit, June 2017

A Drug Policy for the 21st Century

Sure you can quit drugs - but first you have to survive

Maryland s Good Samaritan Law

Risk factors of opioid-related overdose among. opioid users in an acute care setting: a prospective cohort study. John Haight.

A Randomized Trial of Continued Methadone Maintenance Vs. Detoxification in Jail

Whatcom County. Opioid Abuse. Prevention & Response Plan

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

Improving the Quality of Addiction Treatment

Aetna s Initiative on the Opioid Epidemic

A Predictive Model of Homelessness and its Relationship to Fatal and Nonfatal Opioid Overdose

Harm Reduction and Syringe Exchange Programs in the City and County of Los Angeles

Ventura County Opioid Solutions Summit Preventing Accidental Overdose: NO O.D. Overdose Prevention Project August 29, 2017

Transcription:

Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation. Alex H. Kral, PhD Director Behavioral and Urban Health Program RTI International San Francisco Overdosekonferansen, Bergen, Norway August 31, 2015 www.rti.org RTI International is a trade name of Research Triangle Institute

Overview Timeline Research Activity 1998-2000 Observational studies to assess scope of opioid overdose problem 1999-2000 Feasibility studies to assess viability of naloxone intervention 2001-2002 Pilot naloxone intervention study 2003-2014 Evaluation of naloxone intervention 2015 - Implementation science approach to assessing how to best implement naloxone interventions

San Francisco Bay Area Map Population Sizes 2015 San Francisco: 849,774 Oakland: 390,724 Richmond: 103,701 3

Observational Studies Scope of opioid overdose problem in San Francisco Nonfatal Overdoses Fatal Overdoses 4

Prevalence and Factors Associated with Nonfatal Opioid Overdose among People who Inject Heroin 1,427 people who inject heroin recruited in 1998/1999 using targeted sampling in SF. 48% had ever had an overdose, 33% had experienced >1 overdose, and 13% had recent overdose. In multiple logistic regression, recent OD was associated with being: Younger, arrested >2 times past year, Drinking >3 alcoholic drinks per day, participated in methadone detoxification during the past year, and being homeless. 5 Seal, K. H., Kral, A. H., Gee, L., Moore, L. D., Bluthenthal, R. N., Lorvick, J., et al. (2001). Predictors and prevention of non-fatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998 1999. American Journal of Public Health, 91, 1842 1846.

Opioid Overdose Mortality, SF 1997-2000 Davidson, P. J., McLean, R. L., Kral, A. H., Gleghorn, A. A., Edlin, B. R., & Moss, A. R. (2003). Fatal heroin-related overdose in San Francisco 1997 2000: A case for targeted intervention. Journal of Urban Health, 80, 261 273. 6

Feasibility of Peer Naloxone Intervention Chicago Recover Alliance started providing naloxone and overdose training in 1999 at their syringe exchange sites. Shortly thereafter, San Francisco Needle Exchange started an underground naloxone intervention with their participants. Both of these early interventions involved substantial education components that involved CPR training and many hours of attendance. We decided to assess whether people who inject drugs (PWID) would be interested in such trainings. Sporer, K., & Kral, A. H. (2007). Prescription naloxone: A novel approach to heroin overdose prevention. Annals of Emergency Medicine, 49(2), 172 177.

Feasibility of Peer Naloxone Intervention 1999-2000 Survey of 82 street-recruited PWID in San Francisco 89% had ever witnessed an overdose 90% of them used lay interventions 51% had called 911 for ambulance 87% were strongly in favor of being trained and receiving naloxone. Seal, K. H., Downing, M., Kral, A. H., Singleton-Banks, S., Hammond, J. P., Lorvick, J., et al. (2003). Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: A survey of street-recruited injectors in the San Francisco Bay Area. Journal of Urban Health, 80, 291 301.

Opiate Overdose Pilot Intervention 2001 Pilot study of an overdose prevention and naloxone distribution intervention, 2001 (N = 24) Offered study participation to twelve couples who had participated in our larger study. Trained them in overdose prevention, naloxone use, and CPR over two sessions totaling 8 hours. Provided naloxone. Interviewed them at 6 months follow-up. Seal, K. H., Thawley, R., Gee, L., Bamberger, J., Kral, A. H., Ciccarone, D., et al. (2005). Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. Journal of Urban Health, 82, 303 311. 9

Opiate Overdose Pilot Intervention 2001 Pilot study of an overdose prevention and naloxone distribution intervention, 2001 (N = 24) Six Months Post-Intervention Participants witnessed 20 heroin overdoses. CPR and/or rescue breathing performed in 16 events (80%). Naloxone administered in 15 events (75%). Naloxone or CPR administered in 19 events (95%). All 20 overdose victims survived. Seal, K. H., Thawley, R., Gee, L., Bamberger, J., Kral, A. H., Ciccarone, D., et al. (2005). Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. Journal of Urban Health, 82, 303 311. 10

The DOPE Project in San Francisco From September 2003 to September 2010: 2,318 individuals were trained and prescribed naloxone through the DOPE Project 1,312 refilled naloxone prescriptions 502 reports of using naloxone during an opiate overdose event. 174 Group trainings (Methadone programs, jail, SROs), 1,770 participants 113 Service Provider trainings, 1,677 participants There is an updated study by Phillip Coffin et al recently published (Rowe et al Addiction August 2015), which I think he will speak about at this conference. Enteen, L., Morse, P., Davidson, P., Stanley, T. W., Bamberger, J., & Kral, A. H. (2010). Naloxone distribution in San Francisco: An effective strategy in preventing fatal opioid overdose. Journal of Urban Health, 87(6), 931 941.

Heroin-related Deaths, San Francisco, 1999-2012 140 120 100 Naloxone distribution begins Slide provided by Phillip Coffin New Enrollments Refills Reversals Heroin deaths 700 600 500 80 400 60 300 40 200 20 100 0 2000 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 0 *Heroin death data (left axis) compiled from San Francisco Medical Examiner Reports, www.sfgsa.org, fitted to tailing fiscal year, no data for 2001-2002, 2012 deaths preliminary estimate; Naloxone data (right axis) from DOPE Project enrollments and refills

Aims of New Implementation Science Project funded by NIDA In 2010 there were 16,651 deaths in the United States due to opioid overdose, a 3-fold increase in last decade. One of the main risk factors for opioid overdose is community reentry following incarceration, mainly because of the diminished opioid tolerance that occurs during periods of non-use while incarcerated. Binswanger et al. s study of post-release mortality in Washington state, showed that the risk of overdose death among former inmates during the 2 weeks immediately following release from incarceration was 129 times that of other state residents. 13

Aims of New Implementation Science Project funded by NIDA Aim 1.To identify barriers and facilitators to and develop solutions for the implementation of overdose education and naloxone distribution (OEND) programs in venues that target people exiting incarceration and their family members (e.g., jails, correctional visiting centers, community supervision offices, reentry organizations). Aim 2. To pilot the implementation of OEND in two promising venues identified in Aim 1 with the goal of assessing feasibility and acceptability of the implementation process among venue stakeholders. Aim 3. To develop a manual addressing the key factors and lessons learned about the implementation of OEND in venues that target people exiting incarceration and their family members for use in a subsequent implementation trial. 14

Implementation Science Project Opioid Overdose Deaths per Number of Jail Facilities Total Jail CA State Prison Yes/No Type of Number of Re-entry Focused County Year Capacity Community Programs Alameda 215 2 4,800 No Urban/ Suburban 8 Marin 33 1 293 Yes Suburban None Santa Clara 140 4 4,692 No Urban/ Suburban 1 Sonoma 78 2 1,177 No Suburban/ Rural None 15

Acknowledgements Contributors to this work over the years including Jennifer Lorvick, Peter Davidson, Eliza Wheeler, Ricky Bluthenthal, Lynn Wenger, Alexis Martinez, Karl Sporer, Brian Edlin, Karen Seal, and Dan Ciccarone. Slide contributions from Phillip Coffin Funding source: National Institute on Drug Abuse. 16

Contact Information Alex H. Kral, PhD 351 California Street Suite 500 San Francisco, CA 94104 USA Mobile phone +1 415 407 0752 Email akral@rti.org 17